Please assess the completion status of the following clinical trial:

Trial Title: Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Individuals will be identified from within the adult allogeneic BMT program at Mayo Clinic in Rochester, Minnesota~* Adults prescribed tacrolimus for treatment or prevention of Graft Versus Host Disease (GVHD)~Exclusion Criteria:~* Vulnerable populations~* Patients with contraindications to tacrolimus, inclusive of hypersensitivity, history of posterior reversible encephalopathy syndrome or calcineurin-inhibitor induced thrombotic microangiopathy~* Lacking the capacity to consent in English and declining to participate in research

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Allogeneic blood or marrow transplantation (Type: EXPERIMENTAL): Subjects undergoing allogeneic blood or marrow transplantation (BMT) at Mayo Clinic in Rochester Minnesota

Based on this trial design, predict the completion outcome and termination type (if applicable).